Macquarie Group LTD Charles River Laboratories International, Inc. Transaction History

Macquarie Group LTD

$85.1 Billion
Q2 2024

A detailed history of Macquarie Group LTD transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Macquarie Group LTD holds 2,311 shares of CRL stock, worth $484,431. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,311

Previous 34,635 93.33%

Holding current value

$484,431

Previous $9.38 Million 94.92%

% of portfolio

0.0%

Previous 0.01%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 09, 2024	SELL	$206.39 - $268.73 $6.67 Million - $8.69 Million	-32,324 Reduced 93.33%	2,311 $477,000
Q1 2024 May 14, 2024	BUY	$203.52 - $273.43 $1.25 Million - $1.68 Million	6,135 Added 21.53%	34,635 $9.38 Million
Q4 2023 Feb 14, 2024	BUY	$164.52 - $238.84 $2.17 Million - $3.16 Million	13,214 Added 86.45%	28,500 $6.74 Million
Q3 2023 Nov 14, 2023	SELL	$194.44 - $217.61 $115,691 - $129,477	-595 Reduced 3.75%	15,286 $3 Million
Q2 2023 Aug 14, 2023	SELL	$183.71 - $210.25 $1.02 Million - $1.17 Million	-5,555 Reduced 25.91%	15,881 $3.34 Million
Q1 2023 May 15, 2023	BUY	$191.89 - $259.92 $2.78 Million - $3.77 Million	14,508 Added 209.41%	21,436 $4.33 Million
Q4 2022 Feb 21, 2023	SELL	$197.11 - $250.07 $719,845 - $913,255	-3,652 Reduced 34.52%	6,928 $1.51 Million
Q3 2022 Nov 14, 2022	BUY	$182.44 - $250.54 $885,381 - $1.22 Million	4,853 Added 84.74%	10,580 $2.08 Million
Q2 2022 Aug 15, 2022	BUY	$204.13 - $302.4 $921,238 - $1.36 Million	4,513 Added 371.75%	5,727 $1.23 Million
Q1 2022 May 16, 2022	SELL	$255.51 - $362.11 $24,528 - $34,762	-96 Reduced 7.33%	1,214 $345,000
Q4 2021 Feb 11, 2022	SELL	$351.38 - $448.68 $262,832 - $335,612	-748 Reduced 36.35%	1,310 $493,000
Q3 2021 Nov 12, 2021	SELL	$372.64 - $458.3 $126,324 - $155,363	-339 Reduced 14.14%	2,058 $849,000
Q2 2021 Aug 13, 2021	BUY	$294.17 - $371.65 $181,502 - $229,308	617 Added 34.66%	2,397 $887,000
Q1 2021 May 14, 2021	SELL	$249.67 - $299.48 $123,586 - $148,242	-495 Reduced 21.76%	1,780 $515,000
Q4 2020 Feb 16, 2021	BUY	$222.0 - $252.62 $35,076 - $39,913	158 Added 7.46%	2,275 $568,000
Q3 2020 Nov 13, 2020	BUY	$175.56 - $226.45 $17,556 - $22,645	100 Added 4.96%	2,117 $479,000
Q2 2020 Aug 11, 2020	BUY	$118.84 - $189.72 $82,950 - $132,424	698 Added 52.92%	2,017 $352,000
Q4 2019 Feb 14, 2020	SELL	$126.05 - $152.76 $219,327 - $265,802	-1,740 Reduced 56.88%	1,319 $201,000
Q3 2019 Nov 14, 2019	SELL	$125.07 - $143.67 $90,800 - $104,304	-726 Reduced 19.18%	3,059 $405,000
Q2 2019 Aug 14, 2019	BUY	$123.4 - $148.55 $322,937 - $388,755	2,617 Added 224.06%	3,785 $538,000
Q1 2019 May 15, 2019	BUY	$104.82 - $146.73 $111,947 - $156,707	1,068 Added 1068.0%	1,168 $170,000
Q4 2018 Feb 15, 2019	BUY	$105.09 - $137.23 $10,509 - $13,722	100 New	100 $11,000
Q3 2018 Nov 15, 2018	SELL	$112.11 - $134.54 $44,844 - $53,816	-400 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$102.37 - $117.25 $40,948 - $46,900	400 New	400 $45,000

Others Institutions Holding CRL

# of Institutions

732

Shares Held

51.8M

Call Options Held

233K

Put Options Held

236K

View Full List

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

Ticker CRL
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 50,863,300
Market Cap $10.7B
Description
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...

More about CRL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Macquarie Group LTD, based on Form 13F filings with the SEC.

News

Stay updated on Macquarie Group LTD with notifications on news.

Account

Macquarie Group LTD Charles River Laboratories International, Inc. Transaction History